Wegovy Cost Without Insurance: US Prices and Savings Options

Wegovy can be expensive without insurance, but the manufacturer now offers a substantially lower self-pay route than the drug’s full cash/list price. For US patients paying out of pocket, the most useful starting point is the current NovoCare pricing for the Wegovy pen, followed by a like-for-like comparison of pharmacy, insurance and access costs.

Quick Answer

For the Wegovy pen, Novo Nordisk currently lists a limited-time self-pay price of $199 per month for the first two monthly fills of the 0.25 mg or 0.5 mg dose for eligible new patients through December 31, 2026. After that, the published self-pay price is $349 per month for the 0.25 mg, 0.5 mg, 1 mg, 1.7 mg and 2.4 mg pens. Wegovy HD 7.2 mg is $399 per month. Eligibility and restrictions apply, and program terms can change.

Last updated: September 2026
•
Market: United States

1. Check the Manufacturer Program First

Novo Nordisk’s current NovoCare program is the clearest primary-source starting point for patients paying without insurance. Eligible patients new to the Wegovy Savings Offer or NovoCare Pharmacy can pay $199 per month for the first two monthly fills of the 0.25 mg or 0.5 mg pen through December 31, 2026. The published self-pay price after the introductory fills is $349 per month for Wegovy 0.25 mg, 0.5 mg, 1 mg, 1.7 mg and 2.4 mg pens, while Wegovy HD 7.2 mg is $399 per month. Novo Nordisk states that eligibility and restrictions apply and that it may modify or cancel the program.

Important

Manufacturer savings programs can have eligibility requirements and their terms can change. Check the current program directly before relying on a quoted saving or self-pay amount.

2. Compare the Same Prescription Across Pharmacies

The manufacturer self-pay route is not the only price worth checking. Retail pharmacy cash prices and discount-card prices can differ, so compare the same Wegovy form, strength and quantity. Also check whether a quoted price is medication-only or includes a consultation, membership or delivery fee. MediSearcher does not currently have an active commercial relationship with a Wegovy pricing provider on this page.

When comparing prices, make sure you are looking at the same medication, strength, quantity and supply period. Insurance copays, pharmacy cash prices, discount prices and manufacturer programs are different payment routes and may not be directly comparable.

3. Re-check Insurance and Formulary Rules

Commercially insured patients may have different costs from self-pay patients. Novo Nordisk currently advertises eligible commercial-insurance savings of as little as $25 per month, subject to program limits and restrictions; government beneficiaries are excluded from that savings offer. Coverage, formularies and prior-authorization rules vary by plan, so check the insurer’s current terms rather than assuming Wegovy is either covered or excluded.

4. Understand Online and Telehealth Access

Wegovy requires a prescription. Patients can fill a prescription through a local pharmacy, and Novo Nordisk also provides a NovoCare Pharmacy home-delivery route for eligible self-pay patients. Telehealth may provide access to a licensed clinician when medically appropriate, but an online consultation does not guarantee a Wegovy prescription. Compare the cost of clinical care separately from the medication price.

Prescription required

Wegovy is a prescription medication. A legitimate online or telehealth service should involve an appropriate evaluation by a licensed healthcare professional and should not guarantee a prescription before that evaluation.

5. If Wegovy Is Still Unaffordable

If Wegovy remains unaffordable, ask a licensed clinician or pharmacist about covered treatment options rather than switching medication on price alone. Different GLP-1 medicines have different FDA-approved uses, dosing and eligibility requirements. For product background, read the Wegovy medication reference. For payment and coverage comparisons, read Ozempic Vs Wegovy US cost comparison.

Frequently Asked Questions

Can I get Wegovy without insurance?

Yes. A prescription is still required, but eligible self-pay patients can use Novo Nordisk’s current NovoCare pricing. For the Wegovy pen, eligible new patients can currently pay $199 per month for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, followed by the published $349 monthly self-pay price for standard pen doses.

Does Wegovy have a manufacturer savings program?

Yes. Novo Nordisk currently offers self-pay pricing and a commercial-insurance savings offer. For eligible commercially insured patients, the manufacturer advertises a price as low as $25 per month, subject to program limits and restrictions. Self-pay pricing is separate and varies by dose and eligibility.

Can I get a Wegovy prescription online?

A licensed telehealth clinician may prescribe Wegovy when medically appropriate, but completing an online visit does not guarantee a prescription. Novo Nordisk also provides information about telehealth options and a NovoCare Pharmacy home-delivery route for eligible patients with a valid prescription.

Sources and Verification

Pricing programs, eligibility requirements and medication access can change. MediSearcher checked the sources below on 2026-09-17. Verify current terms with the provider, manufacturer, pharmacy or insurer before purchasing.

Editorial note: MediSearcher does not rank providers according to commission payments. Prices, savings programs and availability should be independently verified because they can change.

Medical disclaimer: This page is for general informational and price-comparison purposes. It does not provide medical advice or recommend a particular medication. Consult a licensed healthcare professional before starting, stopping or changing prescription treatment.

About the author

Mattias Hagman

Dr Mattias Hagman is the founder and editor of MediSearcher. He holds a PhD from the University of Sydney and has a background in academic research and scientific publishing. At MediSearcher, he researches online pharmacy services, medication access, consumer safety and the quality of health information available online.

View all articles by Mattias Hagman →